Neuropharmacological effects of ?-adrenoceptor agonists and the relationship between nonadrenaline and 5-hydroxytryptamine function in the rodent brain

Neuropharmacological effects of ?-adrenoceptor agonists and the relationship between nonadrenaline and 5-hydroxytryptamine function in the rodent brain

Bibliographic Details
Main Author:	Nimgaonkar, V
Format:	Thesis
Published:	1984

Similar Items

β-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses
by: Cowen, P, et al.
Published: (1982)

beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.
by: Cowen, P, et al.
Published: (1982)

Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.
by: Green, A, et al.
Published: (1984)

Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
by: Nimgaonkar, V, et al.
Published: (1983)

5-Hydroxytryptamine and punishment.
by: Tye, N, et al.
Published: (1977)

Studies on the 5-hydroxytryptamine (serotonin) content in human brain /
by: 443349 Costa, E., et al.

Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles
by: Rachel A. Matt, et al.
Published: (2023-08-01)

The Effect of β2-Adrenoceptor Agonists on Leucocyte-Endothelial Adhesion in a Rodent Model of Laparotomy and Endotoxemia
by: Mansoor Nawaz Bangash, et al.
Published: (2020-05-01)

High affinity agonist binding to cloned 5-hydroxytryptamine2 receptors is not sensitive to GTP analogs.
by: Szele, F, et al.
Published: (1993)

The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression
by: Simeng Gu, et al.
Published: (2022-04-01)

Challenges in β-adrenoceptor agonist drug development
by: Jonathan R. S. Arch
Published: (2011-04-01)

Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials
by: Wenqiao Fu, et al.
Published: (2022-11-01)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
by: Ivan V. Pozhidaev, et al.
Published: (2020-04-01)

On the Site and Mechanism of Action of β-Adrenoceptor Agonists in the Bladder
by: Karl Erik Andersson
Published: (2017-03-01)

Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists
by: Khadija Ayed, et al.
Published: (2020-10-01)

YH12852, a Potent and Selective Receptor Agonist of 5‐hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation
by: Hyun A. Lee, et al.
Published: (2021-03-01)

Smell and Stress Response in the Brain: Review of the Connection between Chemistry and Neuropharmacology
by: Yoshinori Masuo, et al.
Published: (2021-04-01)

INTRODUCTION TO NEUROPHYSIOLOGY AND NEUROPHARMACOLOGY OF MEMORY FUNCTIONS
by: Weiskrantz, L
Published: (1981)

Recent views on the role of 5-hydroxytryptamine in depression
by: Cowen, P
Published: (1988)

The estimation of 5-hydroxytryptamine (serotonin) in biological tissues /
by: 432134 Udenfriend, Sidney, et al.

Screening aptamers for 5-hydroxytryptamine receptor and its anti-depressant function
by: SHAO Zhi-ding, GAO Xue, REN Jing, TANG Xiao-lei
Published: (2022-10-01)

Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor
by: Qing Wang, et al.
Published: (2021-01-01)

Neuropharmacological studies of antidepressant action on brain dopamine systems
by: Ainsworth, K, et al.
Published: (1998)

Neuropharmacological modulation of cognitive deficits after brain damage.
by: Parton, A, et al.
Published: (2005)

BRONCHODILATOR AND TOCOLYTIC FEATURES OF β<sub>2</sub>-ADRENOCEPTOR AGONISTS
by: S. Ya. Skachilova, et al.
Published: (2019-01-01)

Combining electrophysiology with fMRI to investigate neuropharmacological modulation of brain function in the rat
by: Martin, C, et al.
Published: (2009)

The α2-Adrenoceptor Agonist Dexmedetomidine in Current Sedation Practice
by: I. A. Kozlov
Published: (2013-04-01)

A Selective Pharmacophore Model for β2-Adrenoceptor Agonists
by: Mao-Sheng Cheng, et al.
Published: (2009-11-01)

A Clinician’s Perspective on the Mechanism of β-Adrenoceptor Agonists in the Bladder
by: Tack Lee
Published: (2017-03-01)

CoMFA study on selective human ß3-adrenoceptor agonists
by: P. Senthil Kumar, et al.
Published: (2005-04-01)

Neuropharmacology of performance monitoring.
by: Jocham, G, et al.
Published: (2009)

Neuropharmacology of Antiseizure Drugs
by: Tahir Hakami
Published: (2021-09-01)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2021-08-01)

STUDIES ON COGNITIVE AND NEUROPHARMACOLOGICAL CHANGES IN ANIMAL MODEL BY DOPAMINE (D2/D3) AGONIST AND 5HT3 ANTAGONIST
by: Meh Jabeen, et al.
Published: (2023-10-01)

Advance on association between 5 - hydroxytryptamine and non - motor symptoms in Parkinson's disease
by: SHI Ruo-lin, et al.
Published: (2024-06-01)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2022-10-01)

Blood–Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer?
by: Guillaume Becker, et al.
Published: (2021-11-01)

Clinical manifestations of combined methamphetamine with morphine and their effects on brain dopamine and 5-hydroxytryptamine release in mice
by: Shing-Hwa Liu, et al.
Published: (2015-01-01)

Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
by: Fitzpatrick Brendan, et al.
Published: (2014-05-01)

A population pharmacokinetic‐pharmacodynamic model of YH12852, a highly selective 5‐hydroxytryptamine 4 receptor agonist, in healthy subjects and patients with functional constipation
by: Siun Kim, et al.
Published: (2021-08-01)